Multi‐model averaging improves the performance of model‐guided infliximab dosing in patients with inflammatory bowel diseases
暂无分享,去创建一个
S. Vermeire | M. Ferrante | S. Wicha | J. Sabino | E. Dreesen | A. Outtier | D. Thomas | Zhigang Wang | W. Kantasiripitak | A. Kensert